Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
-
J Coll Physicians Surg Pak · Apr 2023
Clinical and CT Imaging Differences Between Gastric Schwannoma and Gastric Leiomyoma.
To determine whether computed tomography (CT) imaging features can be used to differentiate gastric schwannoma (GS) from gastric leiomyoma (GL) and to develop a nomogram as a predictive model. ⋯ Gastric leiomyoma, Gastric schwannoma, Computed tomography, Diagnosis.
-
J Coll Physicians Surg Pak · Apr 2023
Insulin Resistance and the Prognosis in Diffuse Large B-cell Lymphoma.
To investigate whether insulin resistance (IR) affects the prognosis in patients with diffuse large B-cell lymphoma (DLBCL). Place and Duration of the Study: The Fourth Hospital of Hebei Medical University, Shijiazhuang, China, from September 2017 to December 2021. ⋯ Insulin resistance, Diffuse large B-cell lymphoma, Overall survival, Prognosis.
-
J Coll Physicians Surg Pak · Apr 2023
Observational Study4D Transperineal Ultrasound for the Diagnosis and Classification of Stress Urinary Incontinence in Postmenopausal Women.
To explore 4D transperineal ultrasound (TPUS) parameters distinguishing urethral hypermobility (UH) and intrinsic sphincter deficiency (ISD) in stress urinary incontinence (SUI). ⋯ Stress urinary incontinence, Transperineal ultrasound, Valsalva leak point pressure, Urethral hypermobility, Intrinsic sphincter deficiency.
-
J Coll Physicians Surg Pak · Apr 2023
Grading Intraductal Carcinoma of the Prostate; ISUP versus GUPS Recommendations.
To evaluate the frequency of intraductal component (IDC-P) in prostatic adenocarcinoma and its effect on the final grade using the ISUP and GUPS grading system. ⋯ Prostatic adenocarcinoma, Intraductal carcinoma, IDC-P, ISUP, GUPS, Gleason Grade group.
-
J Coll Physicians Surg Pak · Apr 2023
Observational StudyOutcomes of Chemotherapy plus Cetuximab as First-line Treatment in Patients with Metastatic, Recurrent, Unresectable Head and Neck Cancers: Real-life Data.
To examine the treatment outcomes of the EXTREME regimen as the first-line therapy for recurrent/metastatic squamous cell carcinoma of the head and neck. ⋯ Cetuximab, Head and neck cancer, Chemotherapy.